Site Care Partner - Oncology
ICON plc
Summary
At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON's global expertise. As a Site Care Partner at ICON, you will foster relationships with clinical trial sites, enhancing site engagement, and contribute to the advancement of innovative treatments and therapies.
Job description
What You Will Do
You will contribute to clinical research activities, taking responsibility for your deliverables and working collaboratively. Key responsibilities include:
- Building and maintaining strong relationships with key stakeholders at clinical trial sites, including principal investigators, site coordinators, and research staff.
- Providing support and guidance to site staff on study protocols, procedures, and regulatory requirements, ensuring compliance and successful study conduct.
- Identifying opportunities to improve site engagement and optimize site performance through regular communication and feedback mechanisms.
- Collaborating with internal teams to develop and implement site engagement strategies tailored to the specific needs of each study and site.
- Monitoring site performance metrics and providing regular updates to study teams on site engagement activities and outcomes.
Your Profile
You will bring relevant clinical research experience, along with the following qualifications and skills. Required qualifications and experience:
- Oncology experience required
- Bachelor's degree in life sciences or a related field.
- Previous experience in clinical research, site management, or a related field preferred. (5-7 years)
- Strong interpersonal and communication skills, with the ability to build rapport and establish effective working relationships with diverse stakeholders.
- Prior start-up experience, including Site Identification, Site Selection, and Site Initiation Visits (SIVs)
- Excellent organizational and problem-solving skills, with the ability to prioritize and manage multiple tasks simultaneously.
- Knowledge of ICH-GCP guidelines and regulatory requirements for clinical trials.
- Willingness to travel as required (approximately 60%)
- Pacific Region
Requirements
- Oncology experience required
- Bachelor's degree in life sciences or a related field
- Previous experience in clinical research, site management, or a related field preferred (5-7 years)
- Strong interpersonal and communication skills
- Prior start-up experience including Site Identification, Site Selection, and Site Initiation Visits (SIVs)
- Excellent organizational and problem-solving skills
- Knowledge of ICH-GCP guidelines and regulatory requirements for clinical trials
- Willingness to travel approximately 60%
Benefits
- Competitive base salary
- Performance incentives
- Medical, Dental & Vision
- Retirement & Pension Plans
- Life Assurance
- Disability Coverage
- Employee Assistance Programme
- Wellbeing Resources
- Learning & Development
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.